Converging data now suggest that augmenting SIRT3 activity may be beneficial in progressive neurodegenerative diseases such as AD and PD, and that modulating SIRT3 activity may also provide protection in different types of stroke depending on context. The gene discussed is SIRT3; the disease is stroke disorder.